HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026
HUTCHMED has announced the upcoming presentation of promising preclinical data for HMPL-A580, a first-in-class PI3K/PIKK-EGFR Antibody-Targeted Therapy Conj...
Every story
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2713–2736 of 3,526
CAPITALE HOSTS 750 GUESTS FOR THE NEXT STEP’S 10-YEAR GALA, RAISING $500,000 TO SUPPORT ISRAEL MEDICAL FUND CENTER
The Next Step organization recently celebrated a decade of impact at Capitale in New York City, highlighting its mission to support amputees through communi...
Life Bio’s Trial: Is the FDA Warming to Rejuvenation?
Life Biosciences is poised to revolutionize the field of longevity with its upcoming human trials for ER-100, an epigenetic therapy aimed at cellular reprogramm...
significant
Life Bio’s Trial: Is the FDA Warming to Rejuvenation?
Life Biosciences is advancing the field of rejuvenation therapies by initiating the first human trials of ER-100, an epigenetic treatment aimed at partially...
significant
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
ImmuCell Corporation has reported a 28.4% increase in total sales for Q1 2026, reaching $10.4 million compared to the same period in 2025. Domestic sale...
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026
RxSight, Inc. has achieved a significant milestone with over 300,000 Light Adjustable Lens® (LAL®) implants performed since its launch, as announced ahead o...
Data on the Effective Long Term Treatment of Transthyretin Amyloidosis
Acoramidis, a novel therapeutic agent, has shown promising long-term efficacy in treating transthyretin amyloid cardiomyopathy (ATTR-CM), as evidenced by data...
significant
Peloton named Movement Partner for The Longevity Show 2026
Peloton has been named the Movement Partner for The Longevity Show 2026, marking a significant shift in the longevity field towards integrating physical activ...
WHOOP’s $575m raise backs always-on health
WHOOP, the human performance company recognized for its innovative screenless wristband, has secured $575 million in Series G funding, achieving a valua...
Ergodyne Readies Work Crews for the Dangers of Warmer Temps
Ergodyne has launched a new line of cooling gear and worksite shelters aimed at mitigating heat stress risks for workers during the upcoming summer months. Th...
Tiny gene reveals splicing’s role in disease
Researchers from the University of Oxford and the Francis Crick Institute have elucidated the functional consequences of mutations in the RNU4-2 non-coding...
significant
Life Biosciences lands $80m to push cell reset therapy
Boston-based biotech Life Biosciences has secured $80 million in Series D funding to advance its pioneering cell reset therapy, ER-100, which aims to re...
significant
Epia Neuro debuts with stroke-focused BCI
Epia Neuro, a San Francisco-based startup, has launched an implantable brain-computer interface (BCI) aimed at helping stroke survivors regain functional in...
significant
The Timing of Meals Matters for Biological Aging
A recent analysis utilizing data from the National Health and Nutrition Examination Survey (NHANES) has revealed significant correlations between **meal timing*...
significant
The Timing of Meals Matters for Biological Aging
A recent study utilizing data from the National Health and Nutrition Examination Survey (NHANES) reveals a significant relationship between meal timing and...
New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects
Researchers at the 23andMe Research Institute have published a pivotal study in Nature that uncovers genetic predictors influencing the efficacy and side...
Booking Health Releases 2026 Report on Advanced Head and Neck Cancer Treatment for International Patients
Booking Health has released its 2026 report on advanced treatment strategies for head and neck cancer (HNC), highlighting significant advancements in ...
Steadman Philippon Research Institute and Hospital for Special Surgery to Host Vail Hip Summit April 9–11 at Four Seasons Resort Vail
The 2026 Vail Hip Summit, organized by the Steadman Philippon Research Institute (SPRI) in collaboration with the Hospital for Special Surgery (HSS), will t...
ROOT Brands® Addresses the GLP-1 Gap with CRUSH and SCULPT, a Science-Driven Protocol for Metabolic and Muscle Support After Ozempic® and Wegovy®
ROOT Brands® has introduced CRUSH™ and SCULPT™, a targeted nutritional protocol aimed at addressing the “GLP‑1 gap”—a growing concern among healthcare p...
Tekton Research Opens First Multi-Specialty Clinical Research Hub in San Antonio
Tekton Research has launched its first clinical research hub in San Antonio, Texas, enhancing its capabilities in cardiometabolic research and patient-centered...
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities
Psyence Biomedical Ltd. has expanded its clinical site network in Australia from three to five locations, enhancing its capacity to conduct a Phase IIb clinical...
Aeroflow Health Celebrates Wisconsin’s Extension of Postpartum Care
Aeroflow Health has successfully advocated for the passage of Senate Bill 23, now 2025 Wisconsin Act 102, which expands postpartum Medicaid coverage from 60 d...
$30.16+ BN Functional Service Providers Market Forecasts to 2034: Rising Trial Complexity, Cost Pressures, Demand for Flexible & Scalable Outsourcing Models
The global functional service providers (FSPs) market is projected to grow from approximately USD 15.50 billion in 2024 to USD 30.16 billion by 2034...
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
Ritedose Corporation has entered a strategic partnership with Tenpoint Therapeutics to manufacture YUVEZZI™, the first FDA-approved dual-agent eye d...